| Literature DB >> 24151453 |
Gamal Enan1, Seham Abdel-Shafi, Sahar Ouda, Sally Negm.
Abstract
The purpose of this study was to select and characterize a probiotic bacterium with distinctive antimicrobial activities. In this respect, Lactococcus lactis subspecies lactis Z11 (L. lactis Z11) isolated from Zabady (Arabian yoghurt) inhibited other strains of lactic acid bacteria and some food-born pathogens including Listeria monocytogenes, Bacillus cereus and staphylococcus aureus. The inhibitory activity of cell free supernatant (CFS) of L. lactis Z11 isolated from zabady was lost by proteolytic enzymes, heat resistant. Consequently, the active substance(s) of CFS was characterized as a bacteriocin. This bacteriocin has been shown to consist of protein but has no lipidic or glucidic moieties in its active molecule. Its activity was stable in the pH range 2.0 to 7.0 and was not affected by organic solvents. The L. lactis Z11 bacteriocin was produced in CFS throughout the mide to the late exponential phase of growth of the producer organism and maximum bacteriocin production was obtained at initial pH 6.5 at incubation temperature of about 30°C.Entities:
Keywords: Lactococcus lactis subsp. lactis Z11; bacteriocin; inhibitory activity; pathogenic bacteria
Year: 2013 PMID: 24151453 PMCID: PMC3800719
Source DB: PubMed Journal: Int J Biomed Sci ISSN: 1550-9702
Indicator Strains and their sensitivity to CFS from L. lactis Z
| Indicator Strain | Source of strains | AU/ml |
|---|---|---|
|
| ||
|
| LMG 10470 | 1360 |
|
| LMG 14579 | 1200 |
|
| DSM 1104 | 1020 |
|
| MIR 302 | 0 |
|
| MIR 122 | 0 |
|
| MIR 630 | 0 |
|
| LIM-MG1614 | 1880 |
|
| UG1 | 1620 |
|
| Lb706 | 0 |
|
| LMG 8152 | 1220 |
|
| HL2 | 1440 |
LMG, Laboratorium voor Mikrobilogie, Gent culture collection, Universiteit Gent, Belgium; DSM, Deutsche Sammlung von Mikroorganisms und Zellkulturen, Gmb II, Braunschweig, Germany, MIR, Mircen Culture Collection, Ain Shams Faculty of Agriculture, Cairo, Egypt; LIM, Laboratory of Industrial Microbiology and Biocatalysis, Faculty of Bioscience Bioengineering, University of Gent, Belgium; UGI, Universiteit Gent -1 (Enan el al., 1996); Lb706, a bacteriocin producer strain provided by Dr. Schilinger, karlsruch, Germany; HL; Chr. Hansens Laboratorium, Demark, horsholm, Denmark;
Titers of the inhibitory substance in CFS as determined by the critical dilution assay.
Effect of different treatments on the antibacterial activity of CFS
| Treatment | Residual antibacterial activity (Au/ml) |
|---|---|
|
| |
|
| |
| 100°C for 5 min | 1880 |
| 90°C for 5 min | 1880 |
| 80°C for 5 min | 1880 |
| 70°C for 5 min | 1880 |
| 60°C for 5 min | 1880 |
|
| |
| Pepsin | 0 |
| Trypsin | 0 |
| α-Chemdrypsin | 0 |
| Lipase | 1880 |
| Amylase | 1880 |
|
| |
| Acetone | 1880 |
| Petroleum ether | 1880 |
| Methanol | 1880 |
| Ethanol | 1880 |
| Chloroform | 1880 |
Effect of different pH values on the stability of the inhibitory substance produced by L. lactis Z
| pH Value | Bacteriocin activity (AU/ML) |
|---|---|
|
| |
| 2.0 | 1880 |
| 3.0 | 1880 |
| 4.0 | 1880 |
| 5.0 | 1880 |
| 6.0 | 1880 |
| 7.0 | 1840 |
| 8.0 | 600 |
| 9.0 | 400 |
| 10 | 400 |
Figure 1Antibacterial activity of CFS from L. lactis Z11 against (a) Listeria monocytogenes, (b) Bacillus cereus, (c) Staphylococcus aureus, (d) Lactococcus lactis MG 1614 by the agar well diffusion assay using brain heart infusion agar medium.
Figure 2Dynamics of thermal denaturation of L. lactis Z11 bacteriocin at 100°C for 1 h.
Figure 3Growth (CFU/ml) (a) and bacteriocin activity (AU/ml) (b) in M17 broth adjusted at intial pH 5(o), 5.5(Δ), 6.0(〈), 6.5(•), 7.5(▲), 8.0(■), inoculated with L. lactis Zand incubated at 35°C.
Figure 4Growth (CFU/ml) (a) and bacteriocin activity (AU/ml) (b) in M17 broth adjusted at intial pH 6.5, inoculated with L. lactis Z and incubated at 25°C (•), 30°C (▲) and 42°C (■).